The objective of the initiative is to integrate the principles of sustainable development and the circular economy into the operations of a modern healthcare organization, with a focus on reducing the consumption of natural resources, preventing and properly managing waste, reusing and recycling materials and equipment, reducing its environmental footprint, while ensuring high quality and safety in the healthcare services provided.

The initiative addresses the Group’s employees, patients and individuals undergoing diagnostic examinations, partners and suppliers, as well as society and the healthcare system more broadly, through the adoption of a more sustainable and environmentally responsible healthcare delivery model.

Sustainable development is now a strategic priority for the healthcare sector. The delivery of high-quality healthcare services requires advanced technology, energy-intensive infrastructure and complex operational processes, creating the need for a new operating model that combines environmental responsibility, social contribution and responsible corporate governance.

BIOIATRIKI Group, the largest Primary Healthcare Group in Greece, was the first Group in the sector to publish a Sustainability Report (ESG Report), demonstrating its commitment to transparency, accountability and sustainable development. This initiative marked the starting point of a comprehensive operational transformation, in which the principles of Environmental, Social and Governance (ESG) are embedded across every aspect of the Group’s operations.

For BIOIATRIKI, sustainability is not a standalone corporate responsibility programme. It is the way in which investments are planned, infrastructure is operated, people are developed, natural resources are managed and high-quality healthcare services are delivered every day.

Environmental Responsibility with Measurable Impact

In 2025, the Group carried out one of the largest medical technology equipment renewal programmes of recent years, installing 176 new high-technology and energy-efficient equipment across its facilities. However, the modernization process was not limited to the procurement of new equipment. It was designed around the principles of the circular economy, with the aim of reducing the environmental footprint throughout the equipment lifecycle.

Specifically, 141 pieces of equipment were returned to manufacturers for refurbishment or reuse, 19 pieces of equipment were recycled through licensed waste management systems, and 16 pieces of equipment were made available through resale, extending their lifecycle and significantly reducing electrical and electronic equipment waste. This approach demonstrates that technological modernization can go hand in hand with responsible resource management and sustainable development.

Particular emphasis is also placed on medical waste management. The Group operates an integrated system for waste segregation at source, ensuring the proper classification of hazardous and non-hazardous waste from the point of generation. This practice reduces the amount of waste requiring specialized treatment, enhances safe waste management and limits the overall environmental footprint of healthcare facilities. At the same time, staff receive systematic training on proper waste segregation, while the collection, transportation and final disposal of waste are carried out exclusively by licensed partners, in accordance with environmental legislation.

Reducing Plastic and Infectious Waste in Laboratory Operations

Within the same framework, the Group replaced 8 mL blood collection tubes with 5 mL VACUTAINER tubes, reducing plastic consumption and, consequently, the volume of infectious medical waste generated.

This action is particularly significant because it concerns the core of our daily operations. With 18,315,927 laboratory tests performed, we fully recognize that even a small improvement in a material used on a daily basis can, when implemented at scale, translate into a substantial environmental benefit.

The use of smaller-volume tubes, where scientifically and operationally feasible, is a characteristic example of integrating waste prevention and more efficient use of natural resources into the Group’s core operational processes. It is therefore not simply an environmental initiative, but an ESG practice embedded in the way we deliver healthcare services every day, connecting operational quality and efficiency with the reduction of our environmental footprint.

Innovation and Sustainable Healthcare Delivery

For the Group, sustainability is directly linked to innovation. The use of advanced Artificial Intelligence technologies in MRI, CT, PET/CT and MyoSPECT diagnostic systems contributes to improving diagnostic quality, enhancing patient safety and optimizing diagnostic processes.

At the same time, the gradual transition to the electronic delivery of imaging examinations and results creates the conditions for a significant reduction in the use of physical media (film and CD/DVD), supporting digital transformation and the sustainable management of resources.

People and Quality

Sustainable development cannot exist without investment in people and quality.

In 2025, the Group achieved the accreditation of 806 examinations under ISO 15189, creating the largest accredited scope of examinations in Greece and one of the largest in Europe. This achievement enhances the reliability of results, increases patient safety and reduces the need for repeat examinations, contributing to the more efficient use of healthcare system resources.

Recognizing that its people are the most important factor in sustainable development, the Group delivered a total of 17,113 training hours in 2025, strengthening the continuous development of skills, knowledge sharing, a culture of quality and the ongoing professional development of employees. At the same time, the average training time reached 10 hours per employee, while 81.5% of the workforce participated in performance evaluation and professional development processes, reinforcing a culture of continuous learning and improvement.

Responsible Governance

The sustainability strategy is supported by strong corporate governance, risk management and quality assurance mechanisms. In 2025, 96 internal audits were conducted, strengthening compliance, process effectiveness and continuous improvement.

The Group’s commitment to business ethics is also reflected in the year’s results, with zero confirmed corruption incidents, zero disciplinary sanctions, zero contract terminations due to corruption and zero related legal cases, confirming the high level of integrity and transparency that characterizes the Group.

From Commitment to Action

The Group’s sustainable development strategy continues with specific commitments for 2026–2027, including the expansion of LED lighting, the installation of Building Management Systems (BMS), further energy upgrades to facilities, the integration of ESG criteria into supplier evaluation, and a 90% reduction in the use of film and CD/DVD through the electronic delivery of imaging results.

This transformation demonstrates that sustainability at BIOIATRIKI Group is not an isolated initiative or a corporate commitment. It represents a new way of operating, in which environmental responsibility, innovation, quality, people development and responsible corporate governance function as an integrated system, creating long-term value for the environment, society and the healthcare system.

The initiative had an overall environmental, social and operational impact, strengthening the sustainable and safe delivery of healthcare services. From an environmental perspective, 176 new medical technology equipment were installed in 2025, of which 141 were refurbished/reused, 19 were recycled and 16 were resold, reducing waste generation and extending equipment lifecycles. At the same time, replacing blood collection tubes from 8 mL to 5 mL reduced plastic consumption and the volume of infectious medical waste.

In terms of quality and patient safety, the accreditation of 806 examinations under ISO 15189 enhanced the reliability of results and the safety of the diagnostic process. On a social level, 17,113 training hours were delivered, strengthening employees’ skills and continuous professional development. At the same time, the use of Artificial Intelligence technologies and the digitalization of results delivery contribute to improving the patient experience, enhancing service efficiency and reducing the use of physical resources.